Form DEF 14A Xilio Development Inc For: 28 April
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Xilio Development Inc (XLO)
Assess today's live Xilio Development Inc (XLO) share price, performance and insights using our live NASDAQ: XLO stock exchange data.
Analyse the historical data and Xilio Development Inc share price performance charts on this page. Our technical summary section provides analysis on Xilio Development share price buy/sell indicators using real-time data (or discuss the Xilio Development (XLO) stock price today with other investors in the Xilio Development NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ XLO share price (ISIN: US98422T2096) to enhance your trading decisions with our free investment tools and resources.
What Is the Xilio Development Inc Share Price Today?
The Xilio Development share price today is 7.900.
What Is the Stock Symbol for Xilio Development Inc
The stock symbol (or 'ticker') for Xilio Development Inc is "XLO."
What Stock Exchange Does Xilio Development Inc Trade On?
Xilio Development Inc is listed and trades on the NASDAQ stock exchange.
Is Xilio Development Inc a Good Stock to Buy?
Determining whether Xilio Development Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Xilio Development Inc share price performance charts on this page. Our technical summary section provides analysis on Xilio Development share price buy/sell indicators using real-time data (or discuss the Xilio Development (XLO) stock price today with other investors in the Xilio Development NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ XLO share price (ISIN: US98422T2096) to enhance your trading decisions with our free investment tools and resources.
What Is the Xilio Development Inc Share Price Today?
The Xilio Development share price today is 7.900.
What Is the Stock Symbol for Xilio Development Inc
The stock symbol (or 'ticker') for Xilio Development Inc is "XLO."
What Stock Exchange Does Xilio Development Inc Trade On?
Xilio Development Inc is listed and trades on the NASDAQ stock exchange.
Is Xilio Development Inc a Good Stock to Buy?
Determining whether Xilio Development Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.700
8.050
52 wk Range
6.465
16.520
Earnings results expected today
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.7008.050
52 wk Range
6.46516.520
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
XLO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
20.000
Upside
+153.16%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
- Form 8K Xilio Development Inc For: 16 April
- Investing.com
- Form DEF 14A Xilio Therapeutics For: 28 April
- Investing.com
- Form DEF 14A Xilio Development Inc For: 28 April
- Investing.com
- Form DEF 14A Xilio Therapeutics For: 28 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 20.000
(+153.16% Upside)
Earnings
Latest Release
16/03/2026
EPS / Forecast
0.81 / -0.07
Revenue / Forecast
13.69M / 10.9M
Compare XLO to Peers and Sector
Metrics to compare | XLO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipXLOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.3x | −7.2x | −0.5x | |
PEG Ratio | −0.03 | 0.01 | 0.00 | |
Price/Book | 1.3x | 4.2x | 2.6x | |
Price / LTM Sales | 1.0x | 8.6x | 3.2x | |
Upside (Analyst Target) | 159.4% | 35.3% | 48.3% | |
Fair Value Upside | Unlock | −7.6% | 5.6% | Unlock |
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company’s pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for patients with metastatic non-small cell lung cancer; Efarindodekin alfa, an investigational, masked IL-12, that is in Phase 2 clinical trial for patients with advanced solid tumors; and Vilastobart, an investigational tumor-activated, Fc-enhanced, high affinity binding anti-CTLA-4 monoclonal antibody. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Xilio Development (NASDAQ: XLO) Share Price Today?
The Xilio Development stock price today is 7.900 USD.
What Stock Exchange Does Xilio Development (XLO) Trade On?
Xilio Development is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Xilio Development?
The stock symbol (also called a 'ticker') for Xilio Development is "XLO."
What Is the Current Xilio Development Market Capitalisation?
As of today, Xilio Development (NASDAQ: XLO) market cap is 45.680M USD.
What Is Xilio Development's (XLO) Earnings Per Share (TTM)?
The Xilio Development EPS is currently -7.733 (Trailing Twelve Months).
When Is the Next Xilio Development Earnings Date?
Xilio Development's next earnings report will be released on 07/05/2026.
Is XLO a Buy or Sell From a Technical Analyst Perspective?
Based on today's Xilio Development moving averages and other technical indicators, the daily buy/sell signal for XLO stock is Strong Sell.
How Many Times Has Xilio Development Stock Split?
Xilio Development has split 1 times. (See the XLO stock split history page for full effective split date and price information.)
How Many Employees Does Xilio Development Have?
Xilio Development has 76 employees, based on their latest Companies House report.
What is the current trading status of Xilio Development (NASDAQ: XLO)?
As of 07/05/2026, Xilio Development (XLO) is trading at a share price of 7.900 USD, with a previous close of 7.710 USD. The stock has fluctuated within a day range of 7.700 USD to 8.050 USD, while its 52-week range spans from 6.465 USD to 16.520 USD.
What Is Xilio Development (XLO) Price Target According to Analysts?
The average 12-month price target for Xilio Development is 20.000 USD, with a high estimate of 20 USD and a low estimate of 20 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +153.16% Upside potential.
What Is the XLO Premarket Price?
XLO's last pre-market stock price is 7.560 USD. The pre-market share volume is 60.000, and the stock has decreased by -0.150, or -1.950%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.